Hematologic Malignancies Symposium

描述（由申请人提供）：我们生活在一个科学快速发展的时代，有时是压倒性的步伐，血液恶性肿瘤的治疗，如白血病、淋巴瘤和骨髓瘤是这种新范式的一个主要例子。新的发展和发现不断改变我们的观点和治疗方法，反映了我们不断努力提高患者的生存率和生活质量。改进治疗方法的学术努力伴随着这些知识的传播，这些知识总是会受到挑战，从而推动该领域向前发展。作为布朗大学沃伦·阿尔珀特医学院的主要教学医院，罗德岛医院和米利亚姆医院的血液学和肿瘤学部门充分意识到，在将新证据应用于我们的日常实践方面，新发展带来的挑战。为此，我们部门将于2011年3月18日在罗德岛普罗维登斯举办第二届恶性血液病研讨会。讲师是全国知名的血液恶性肿瘤管理专家，目标受众是社区从业人员，如医生、研究员、住院医师、执业护士、护士和相关医疗保健专业人员。本次研讨会的主要目的是介绍关于白血病、淋巴瘤和骨髓瘤治疗的最新循证数据，通过病例报告的形式促进热烈的讨论，允许观众提问和回答。这种方法将促进讲师和与会者之间的互动。

DESCRIPTION (provided by applicant): We live in a time in which science develops at a fast, sometimes overwhelming pace, and the management of hematologic malignancies, such as leukemia, lymphoma and myeloma is a prime example of this new paradigm. New developments and discoveries constantly change our perspectives and therapeutic approaches reflecting our constant struggle to improve the survival and quality of life of our patients. The academic effort to improve therapies goes along with the dissemination of such knowledge, knowledge that invariably will be challenged, moving the field forward. The Division of Hematology and Oncology at the Rhode Island and The Miriam Hospitals, as major teaching hospitals for The Warren Alpert Medical School of Brown University, is fully aware of the challenges new developments pose with regard to applying new evidence into our daily practices. For this purpose, our Division is organizing the 2nd Hematologic Malignancy Symposium to take place in March 18, 2011 in Providence, Rhode Island. The lecturers are nationally renowned specialists in the management of hematologic malignancies, and the target audience is community-based practitioners, such as physicians, fellows, residents, nurse practitioners, nurses and allied healthcare professionals. The main objective of this Symposium is to present the most recent evidence-based data on the management of leukemias, lymphomas and myeloma, promoting a lively discussion by means of a case presentation format, allowing questions and answers from the audience. This approach will facilitate the interaction between the lecturers and the attendees. PUBLIC HEALTH RELEVANCE: The 2nd Hematologic Malignancy Symposium will bring to community-based hematology and oncology practitioners in Southern New England the most recent evidence-based data on the management of leukemia, lymphoma, myeloma and other blood cancers through lectures and highly interactive case presentations.